Cancer pain and opioids - past, present, and future

Files

hdl_93445.pdf (631.5 KB)
  (Published version)

Date

2015

Authors

Crawford, G.B.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Oncology & hematology review, 2015; 11(1):56-57

Statement of Responsibility

Gregory B Crawford

Conference Name

Abstract

The Cancer Council Australia and Cancer Institute New South Wales are two Australian organizations that are providing useful resources to support evidence-based prescribing of opioids in cancer pain. Morphine remains the preeminent medication for nociceptive cancer pain. Our understanding of the action of opioids, and how relatively recently these developments are, assists in putting pain and suffering in the context of “total pain.” Increasing understanding of the how pain is understood is leading to new insights with an increasing emphasis on the neuroimmuno- pharmacology of pain.

School/Discipline

Dissertation Note

Provenance

Description

Editorial

Access Status

Rights

This article is published under the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, adaptation, and reproduction provided the original author(s) and source are given appropriate credit.

License

Grant ID

Call number

Persistent link to this record